RSS Bot
07-08-2008, 06:28 AM
Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Expression of the cannabinoid 1 receptor (CB1R), the site of action of the main chemical ingredient of marijuana, is significantly reduced in the brains of individuals with schizophrenia.
More... (http://www.medicalnewstoday.com/articles/114143.php)
More... (http://www.medicalnewstoday.com/articles/114143.php)